Article Versions Notes

Lecka-Ambroziak A, Wysocka-Mincewicz M, Marszałek-Dziuba K, Rudzka-Kocjan A, Szalecki M. Premature Adrenarche in Children with Prader-Willi Syndrome Treated with Recombinant Human Growth Hormone Seems to Not Influence the Course of Central Puberty and the Efficacy and Safety of the Therapy. Life. 2020; 10(10):237. https://doi.org/10.3390/life10100237

Lecka-Ambroziak, Agnieszka, Marta Wysocka-Mincewicz, Kamila Marszałek-Dziuba, Agnieszka Rudzka-Kocjan, and Mieczysław Szalecki. 2020. "Premature Adrenarche in Children with Prader-Willi Syndrome Treated with Recombinant Human Growth Hormone Seems to Not Influence the Course of Central Puberty and the Efficacy and Safety of the Therapy" Life 10, no. 10: 237. https://doi.org/10.3390/life10100237

Lecka-Ambroziak, A., Wysocka-Mincewicz, M., Marszałek-Dziuba, K., Rudzka-Kocjan, A., & Szalecki, M. (2020). Premature Adrenarche in Children with Prader-Willi Syndrome Treated with Recombinant Human Growth Hormone Seems to Not Influence the Course of Central Puberty and the Efficacy and Safety of the Therapy. Life, 10(10), 237. https://doi.org/10.3390/life10100237